VNRX-7145-106: Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination (clinicaltrials.gov) - Jul 10, 2026 - P1 | N=96 | Recruiting | Sponsor: Basilea Pharmaceutica | N=46 ➔ 96 | Trial completion date: Jun 2026 ➔ Dec 2026 | Trial primary completion date: Jun 2026 ➔ Dec 2026
Enrollment change • Trial completion date • Trial primary completion date
|